Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Pharmabiz12m
US FDA grants priority review status to Johnson & Johnson’s TAR-200 NDA in high-risk non-muscle invasive bladder cancer
Raritan, New Jersey Friday, July 18, 2025, 15:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

House passes spending cuts
CBS to end 'The Late Show'
Diagnosed with cancer
Band cancels entire tour
Suspended over doping test
NFL's highest-paid defender
Dies trying to save swimmers
Deodorant recalled
Teen arrested in murder
Sentenced to 30 days in jail
Judge OKs release plan
Hands over Medicaid data
Gets FDA authorization
Diagnosed w/ vein condition
Chicken sausage recalled
10th person dies from fire
Pulls out of All-Star weekend
Weekly jobless claims fall
Lost mother, son rescued
House passes stablecoin bill
Bove clears Senate panel
5 charged in murder case
Dies in paragliding crash
Suspends China travel
Idaho judge lifts gag order
Retail sales rebound
To lower voting age to 16
DOJ seeks one-day sentence
Unveils ChatGPT agent
Iraq mall fire kills dozens
Meta investors settle suit
Gulf Coast flood threat
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy